Abstract:OBJECTIVE:To design, construct and select the optimal replication-defective recombinant adenovirus mediated short hairpin RNA (shRNA) which is transduced into human osteosarcoma cells to silence c-myc gene expression, and to construct the recombinant adenovirus vector expressing c-myc-shRNA and determine its viral titer.METHODS:Three pairs of complementary single-stranded oligonucleotides (ss oligos) were designed and synthesized, and then they were annealed to create a double-stranded oligonucleotide (ds oligos).The ds oligos were cloned into pENTR/U6 vector to produce the shuttle plasmid pENTR/U6-shRNA, which was transduced into osteosarcoma cells by liposome after sequencing. The plasmid with good silence effect was chosen by RT-PCR to perform the LR recombination reaction to the adenovirus backbone plasmid. The expression clone was transfected into HEK293A cells to produce replication-incompetent recombinant adenovirus mediated shRNA against c-myc whose cytopathic effect was observed and viral titer was determined by the viral particle (VP) method and 50% tissue culture infective dose (TCID50).RESULTS:Ds oligos, which was verified by electrophoresis, was cloned into pENTR/U6 vector to produce pENTR/U6-shRNA shuttle plasmid, which was confirmed to be corrected by sequencing. The optimal plasmid with good silence effect was chosen by RT-PCR from the three pairs of double-stranded oligonucleotide. By Pac I enzyme, the linearization replication-defective recombinant adenovirus mediated shRNA was constructed to perform the LR recombination reaction to the adenovirus backbone plasmid. The cytopathic effect and vacuole phenomenon of adenovirus mediated shRNA appeared at 3 days and became obvious at 6 days. The adenovirus virus titer in the first generation was 5.23 x 10(9) VP/mL, and reached 2.26 x 10(12) VP/mL via 3-4 generations' amplification. The viral titer was 10(-3.8)/0.1 mL determined by VP method and TCID50.CONCLUSION:The recombinant adenovirus mediated shRNA c-myc is constructed in vitro through RNA interference technology.

The Construction of Lentivirus-Mediated RNAi Vector Containing Cytochrome C Oxidase

Construction of Microrna Let-7C Lentiviral Vector and Its Overexpression

BC047440 silencing in HepG2 cells mediated by lentiviral vector

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

Construction and Identification of a Vector Inserted with Gene of T7 RNA Polymerase

Construction of hsa-miR-152lentiviral vector and screening of cell strain for stable expression

Construct Recombinant Lentivirus Vector with Math1 and the Expression of Math1 in 293T Cells

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

Construction of Lncrna4.9 Interfering Lentivirus Vector

Construction and Identification of Recombinant Lentiviral Expressing Vectors Formyl-Coa Transferase Gene and Oxalyl-CoA Decarboxylase Gene of Oxalobacter Formigenes from Chinese Feces

Cloning of SARS-CoV-S Gene and Construction of Its Short Interfering RNAs Expression Vector

Construction and Identification of Lentiviral Vector of RNA Interference of CXCR4 Gene

Construction of Htert and Cox-2 Dependent Oncolytic Adenovirus

[Construction of Lentiviral Vector Carrying Human OCT4A Gene and Establishment of Leukemic Cell Line K562 Stably Expressing OCT4A].

Construction and Identification of Eukaryotic Expression Vector for HCMV IE1-GFP Fusion Protein

CONSTRUCTION OF RECOMBINANT ADENOVIRUS VECTOR BY C-MYC SILENCING

Construction of Enhanced Cyan Fluorscent Protein Lentiviral Vector

Construction of Recombinant Vectors Expressing Antisense RNA to CCR5 and Expression in Eukaryotic Cells

TALEN/CRISPR-mediated Engineering of a Promoterless Anti-Viral RNAi Hairpin into an Endogenous Mirna Locus

Construction of A Lentiviral Vector Simultaneously Expressing Active IGF1, EGF and FGF2

Construction and efficacy identification of a lentiviral vector harboring RNAi based on gene NSBP1